Doctor: Abdominal obesity can trigger insulin resistance, diabetes
New: GLP-1 receptor agonist therapy and dual incretin treatment may help patients with type 2 diabetes who are also obese.
Antara News, Republika
New: GLP-1 receptor agonist therapy and dual incretin treatment may help patients with type 2 diabetes who are also obese.
Pediatricians also urge zero screen time for children under two, citing links between device exposure, speech delay and virtual autism.